Medicine & Life Sciences
9-deoxy-delta-9-prostaglandin D2
9%
Acute Myeloid Leukemia
14%
Anemia
25%
Bone Marrow
10%
Bone Morphogenetic Protein 4
14%
cyclopentenone
16%
Erythroblasts
22%
Erythrocytes
24%
Erythroid Cells
8%
Erythroid Precursor Cells
29%
Erythropoiesis
100%
Erythropoietin
13%
Erythropoietin Receptors
15%
Ethylnitrosourea
6%
Experimental Leukemias
6%
Friend murine leukemia virus
57%
Genes
10%
Growth
8%
Hematopoiesis
6%
Hematopoietic Stem Cells
9%
Heme
7%
Homeostasis
6%
Hypoxia
8%
In Vitro Techniques
6%
Inflammation
9%
Leukemia
25%
Leukemia, Erythroblastic, Acute
35%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7%
Liver
6%
macrophage stimulating protein
7%
Macrophages
15%
Mutagenesis
7%
Mutation
19%
Neoplastic Stem Cells
8%
Peroxisome Proliferator-Activated Receptors
9%
Phenotype
5%
Phosphotransferases
12%
podocalyxin
6%
Population
8%
prostaglandin R2 D-isomerase
7%
Prostaglandins
15%
Protein-Tyrosine Kinases
12%
Proteins
9%
Receptor Protein-Tyrosine Kinases
35%
Regeneration
12%
Selenium
28%
Selenoproteins
16%
Spleen
34%
Stem Cells
16%
Virus Diseases
6%
Chemical Compounds
Antileucemic
5%
Cell Surface Marker
6%
Erythropoietin
14%
Intraperitoneal
14%
Metabolite
9%
Mutation
10%
Peroxisome Proliferator Activated Receptor Gamma Antagonist
7%
Prostaglandin
17%
Prostaglandin D2
7%
Prostaglandin J2
10%
Prostaglandins D
8%
Protein
5%
Selenocysteine
5%
